StonvexLoading…
StonvexStonvexStonvexCore line items from ATMP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | £9.71B | £9.35B | £8.57B | £8.03B |
Operating Income | £5.94B | £4.75B | £4.22B | £4.87B |
Net Income | £4.66B | £3.75B | £3.56B | £4.38B |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | £1.25T | £1.22T | £1.19T | £1.20T |
Total Liabilities | £1.18T | £1.16T | £1.12T | £1.14T |
Cash & Equivalents | £229.95B | £200.69B | £208.41B | £219.85B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |